TNXP vs. APH
Compare and contrast key facts about Tonix Pharmaceuticals Holding Corp. (TNXP) and Amphenol Corporation (APH).
Performance
TNXP vs. APH - Performance Comparison
Loading graphics...
TNXP vs. APH - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
TNXP Tonix Pharmaceuticals Holding Corp. | -11.97% | -52.64% | -97.44% | -83.46% | -96.59% | -47.01% | -42.31% | -94.68% | -93.62% | -26.61% |
APH Amphenol Corporation | -6.32% | 96.08% | 41.30% | 31.85% | -11.96% | 35.25% | 22.09% | 34.91% | -6.82% | 31.81% |
Fundamentals
TNXP:
$117.03M
APH:
$162.83B
TNXP:
-$9.34
APH:
$3.34
TNXP:
8.66
APH:
7.00
TNXP:
0.48
APH:
12.14
TNXP:
$13.11M
APH:
$23.09B
TNXP:
$6.47M
APH:
$8.52B
TNXP:
-$123.98M
APH:
$6.89B
Returns By Period
In the year-to-date period, TNXP achieves a -11.97% return, which is significantly lower than APH's -6.32% return. Over the past 10 years, TNXP has underperformed APH with an annualized return of -84.39%, while APH has yielded a comparatively higher 25.30% annualized return.
TNXP
- 1D
- 14.30%
- 1M
- -1.57%
- YTD
- -11.97%
- 6M
- -43.09%
- 1Y
- -23.08%
- 3Y*
- -89.48%
- 5Y*
- -88.80%
- 10Y*
- -84.39%
APH
- 1D
- 6.04%
- 1M
- -13.32%
- YTD
- -6.32%
- 6M
- 2.50%
- 1Y
- 94.00%
- 3Y*
- 46.92%
- 5Y*
- 31.66%
- 10Y*
- 25.30%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
TNXP vs. APH — Risk / Return Rank
TNXP
APH
TNXP vs. APH - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Tonix Pharmaceuticals Holding Corp. (TNXP) and Amphenol Corporation (APH). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| TNXP | APH | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | -0.23 | 2.30 | -2.53 |
Sortino ratioReturn per unit of downside risk | 0.36 | 2.65 | -2.29 |
Omega ratioGain probability vs. loss probability | 1.04 | 1.40 | -0.36 |
Calmar ratioReturn relative to maximum drawdown | -0.40 | 3.23 | -3.63 |
Martin ratioReturn relative to average drawdown | -0.58 | 11.34 | -11.92 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading graphics...
Sharpe Ratios by Period
| TNXP | APH | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | -0.23 | 2.30 | -2.53 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | -0.65 | 1.08 | -1.74 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | -0.60 | 0.93 | -1.53 |
Sharpe Ratio (All Time)Calculated using the full available price history | -0.58 | 0.62 | -1.20 |
Correlation
The correlation between TNXP and APH is 0.16, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Dividends
TNXP vs. APH - Dividend Comparison
TNXP has not paid dividends to shareholders, while APH's dividend yield for the trailing twelve months is around 0.66%.
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
TNXP Tonix Pharmaceuticals Holding Corp. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
APH Amphenol Corporation | 0.66% | 0.55% | 0.79% | 1.07% | 1.06% | 0.89% | 0.80% | 0.89% | 1.09% | 0.80% | 0.86% | 1.01% |
Drawdowns
TNXP vs. APH - Drawdown Comparison
The maximum TNXP drawdown since its inception was -100.00%, which is greater than APH's maximum drawdown of -63.41%. Use the drawdown chart below to compare losses from any high point for TNXP and APH.
Loading graphics...
Drawdown Indicators
| TNXP | APH | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -100.00% | -63.41% | -36.59% |
Max Drawdown (1Y)Largest decline over 1 year | -80.46% | -28.19% | -52.27% |
Max Drawdown (5Y)Largest decline over 5 years | -100.00% | -28.73% | -71.27% |
Max Drawdown (10Y)Largest decline over 10 years | -100.00% | -37.56% | -62.44% |
Current DrawdownCurrent decline from peak | -100.00% | -23.85% | -76.15% |
Average DrawdownAverage peak-to-trough decline | -91.05% | -13.55% | -77.50% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 54.87% | 8.03% | +46.84% |
Volatility
TNXP vs. APH - Volatility Comparison
Tonix Pharmaceuticals Holding Corp. (TNXP) has a higher volatility of 27.68% compared to Amphenol Corporation (APH) at 14.30%. This indicates that TNXP's price experiences larger fluctuations and is considered to be riskier than APH based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading graphics...
Volatility by Period
| TNXP | APH | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 27.68% | 14.30% | +13.38% |
Volatility (6M)Calculated over the trailing 6-month period | 51.44% | 33.98% | +17.46% |
Volatility (1Y)Calculated over the trailing 1-year period | 100.30% | 41.10% | +59.20% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 135.81% | 29.47% | +106.34% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 141.09% | 27.16% | +113.93% |
Financials
TNXP vs. APH - Financials Comparison
This section allows you to compare key financial metrics between Tonix Pharmaceuticals Holding Corp. and Amphenol Corporation. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities